SAINT PETERSBURG, FL, United States, via ETELIGIS INC., 10/24/2014 – – FutureWorld Corp. (OTC Pink: FWDG) (PINKSHEETS: FWDG), a leading provider of advanced technologies and solutions to the global cannabis industry, announces that its wholly-owned subsidiary, CB Scientific, will be offering up to 1,000 test kits for free to parents to test their kid’s Halloween Candy for cannabinoids. To claim your free test, parents can go to checkyourtreats.com or testyourtreats.com before October 27th, 2014. Tests will be sent via regular mail to all legal states.
“The yearly news reminders in the press for parents to check their children’s candy has taken on a new sense of urgency in states where marijuana is legal and is packaged as candy and other edibles.” indicated CEO Sam Talari, “And our PersonalAnalytics home-testing kit is a great option to take preventative measures against any risk. The safety and protection of our children is a matter of paramount importance.”
CB Scientific’s PersonalAnalytics is the first test for consumers that is available for personal use to test for cannabinoids, including THC and CBD, outside of a lab setting. These affordable and high-quality tests provide results in ten minutes or less, and have numerous uses outside of the Halloween setting, including patients who need to use medical cannabis and hemp-related products such as CBD oil.
Both THC and CBD home testing kits are already available at several outlets in Spokane, Washington and Denver, Colorado, specifically head shops, dispensaries and grow stores. The kits are also available for purchase worldwide online at cbscientific.com
ABOUT CB SCIENTIFIC
CB Scientific (http://www.cbscientific.com) is a wholly owned Florida company based in Denver Colorado. CB Scientific is continuing to develop new technologies specifically for cannabis analytics. Senior management team includes Charlie Steinberg and Derek Lebahn. Mr. Steinburg and Mr. Lebahn are some of the primary men advancing gas chromatography testing in Colorado. Mr. Steinburg has also pioneered residual solvent testing for medical cannabis and has always strived to help patients know exactly what they are buying. CB Scientific believes every product sold to patients as "Medical Quality" should be inspected for health benefits, safety, consistency, purity, potency and packaged properly for distribution.
Senior management team of CB Scientific have worked with many of the cannabis industry leaders in Colorado and have also been featured in cannabis industry publications including High Times Magazine, many trade publications, on-air interviews and panel discussions across the United States.
CB Scientific’s focus has been the education and safety of consumers combined with innovation to put power into the hands of the patients. Values that FutureWorld is pleased to embrace while ever striving to raise the bar of cannabis analytics even higher.
About FutureWorld Corp
FutureWorld (Other OTCQB: FWDG), a Delaware corporation, is a U.S. Diversified Holding Company, listed on the Over the Counter exchange, which was formed to capitalize on the burgeoning Cannabis markets globally. FutureWorld, together with its subsidiaries, focuses on the identification, acquisition, development, and commercialization of cannabis related products, such as industrial Hemp. HempTech, a subsidiary of FutureWorld, is a technology division catered to the cannabis and the industrial Hemp market. HempTech provides smart sensor technology, communication network, surveillance security, data analysis for smart cultivation and consultation for the industrial hemp and legal medicinal marijuana. Our wireless agricultural smart sensor networks offer precision to the agriculture, irrigation systems, and greenhouses for the global Hemp industry. FutureWorld and its subsidiaries do not grow, distribute or sell marijuana.
To request further information about FutureWorld, please email us at investors, log onto our website at http://www.futureworldcorp.com or visit us at our Facebook page https://www.facebook.com/futureworldenergy.
This press release may contain forward-looking statements covered within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements relate to, among other things, plans and timing for the introduction or enhancement of our services and products, statements about future market conditions, supply and demand conditions, and other expectations, intentions and plans contained in this press release that are not historical fact and involve risks and uncertainties. Our expectations regarding future revenues depend upon our ability to develop and supply products and services that we may not produce today and that meet defined specifications. When used in this press release, the words "plan," "expect," "believe," and similar expressions generally identify forward-looking statements. These statements reflect our current expectations. They are subject to a number of risks and uncertainties, including, but not limited to, changes in technology and changes in pervasive markets. This release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 27E of the Securities Act of 1934. Statements contained in this release that are not historical facts may be deemed to be forward-looking statements. Investors are cautioned that forward-looking statements are inherently uncertain. Actual performance and results may differ materially from that projected or suggested herein due to certain risks and uncertainties including, without limitation, ability to obtain financing and regulatory and shareholder approval for anticipated actions.
(727) 474-1816 ext. 103
SOURCE: FutureWorld Corp.